TY - JOUR
T1 - Functional interaction of CD154 protein with α5β1 integrin is totally independent from its binding to αIIbβ3 integrin and CD40 molecules
AU - El Fakhry, Youssef
AU - Alturaihi, Haydar
AU - Yacoub, Daniel
AU - Liu, Lihui
AU - Guo, Wenyan
AU - Leveillé, Claire
AU - Jung, Daniel
AU - Khzam, Lara Bou
AU - Merhi, Yahye
AU - Wilkins, John A.
AU - Li, Hongmin
AU - Mourad, Walid
PY - 2012/5/25
Y1 - 2012/5/25
N2 - In addition to its classical CD40 receptor, CD154 also binds to αIIbβ3, α5β1, and αMβ2 integrins. Binding of CD154 to these receptors seems to play a key role in the pathogenic processes of chronic inflammation. This investigation was aimed at analyzing the functional interaction of CD154 with CD40, αIIbβ3, and α5β1 receptors.Wefound that the binding affinity of CD154 for αIIbβ3 is ∼4-fold higher than for α5β1. We also describe the generation of sCD154 mutants that lost their ability to bind CD40 or αIIbβ3 and show that CD154 residues involved in its binding to CD40 or αIIbβ3 are distinct from those implicated in its interaction to α5β1, suggesting that sCD154 may bind simultaneously to different receptors. Indeed, sCD154 can bind simultaneously to CD40 and α5β1 and biologically activate human monocytic U937 cells expressing both receptors. The simultaneous engagement of CD40 and α5β1 activates the mitogen-activated protein kinases, p38, and extracellular signal-related kinases 1/2 and synergizes in the release of inflammatory mediators MMP-2 and -9, suggesting a cross-talk between these receptors.
AB - In addition to its classical CD40 receptor, CD154 also binds to αIIbβ3, α5β1, and αMβ2 integrins. Binding of CD154 to these receptors seems to play a key role in the pathogenic processes of chronic inflammation. This investigation was aimed at analyzing the functional interaction of CD154 with CD40, αIIbβ3, and α5β1 receptors.Wefound that the binding affinity of CD154 for αIIbβ3 is ∼4-fold higher than for α5β1. We also describe the generation of sCD154 mutants that lost their ability to bind CD40 or αIIbβ3 and show that CD154 residues involved in its binding to CD40 or αIIbβ3 are distinct from those implicated in its interaction to α5β1, suggesting that sCD154 may bind simultaneously to different receptors. Indeed, sCD154 can bind simultaneously to CD40 and α5β1 and biologically activate human monocytic U937 cells expressing both receptors. The simultaneous engagement of CD40 and α5β1 activates the mitogen-activated protein kinases, p38, and extracellular signal-related kinases 1/2 and synergizes in the release of inflammatory mediators MMP-2 and -9, suggesting a cross-talk between these receptors.
UR - http://www.scopus.com/inward/record.url?scp=84861551016&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84861551016&partnerID=8YFLogxK
U2 - 10.1074/jbc.M111.333989
DO - 10.1074/jbc.M111.333989
M3 - Article
C2 - 22461623
AN - SCOPUS:84861551016
SN - 0021-9258
VL - 287
SP - 18055
EP - 18066
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 22
ER -